Skip to main content
OpenTrials
Completed

NCT Number: NCT04091555

Evaluation of the Impact of the HL Natural, Inc. Tension Relief Product

The primary hypothesis of the present study is that supplementation with the Tension Relief test product will reduce the severity of symptoms of a tension headache.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Tension Headache Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hawthorne Effect, Inc.

Lafayette, California, 94549, United States

About this study

Patients will begin taking the capsules at the onset of headache symptoms. Onset is defined as the point in time the participant feels that it is necessary to take the test product for relief of symptoms. When the participant decides to take the test product, they will report symptoms in the headache diary prior to taking the product and rate their symptoms on a 10-point Mankoski scale. After consuming the product, the participant will complete a Mankoski scale at 15 minutes, 30 minutes and 1 hour after taking the product. If needed the participant will be allowed to take alternative medication (alternative treatment) after an hour after taking the product. If alternative medication is taken, the participant will record this in their headache diary.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adult candidates who are in overall good health and who suffer from mild to moderate tension headaches.

Participants will be deemed to be in good health if they do not report any of the existing medical conditions asked about in the screening questionnaire.

Exclusion criteria

  • Those who have been diagnosed with migraine headaches.
  • Those who score between 36-49 or 60-78 on screening questionnaire.
  • Is < 18 years of age
  • Those who have been diagnosed with fibromyalgia.
  • Women that are pregnant or breastfeeding.
  • Alcohol consumption more than 7 drinks per week or more than 3 drinks per occasion.
  • Routine recreational drug use such as marijuana.
  • Chronic renal disease
  • Chronic liver disease
  • Allergy to any of the following: Aspirin or any other product including Salicylates, Boswellia, Feverfew, Skullcap, White Willow Bark, Rice Hull, or Vegetable Cellulose.
  • Unable to swallow pills.
  • Unwilling to try test product for relief of pain and tension headache symptoms.
  • Participants who are currently taking any anticoagulation medications daily. (Aspirin, Warfarin, Heparin etc.)

Treatment and study plan

HLNatural Tension

Dietary Supplement

Understand the impact of the supplement on Tension Headaches

Primary outcomes

  1. The Evaluation of the Impact of HLNatural Tension Relief Product for Adults who Suffer from Mild to Moderate Tension Headaches

    Time frame: After taking the test product, the participant will complete a Mankoski pain scale at 15 minutes after the start of the event, 30 minutes after the start of the event, and 1 hour after the start of the event.

    Those subjects who meet the inclusion/exclusion criteria will be invited to be part of the study. The subject will sign consent and complete the required surgery and questionnaires before taking the test product. • At the onset of the headache, the participant will start a Headache Diary and complete a 10-point Mankoski pain scale. • After completing the surveys, the participant will take test product. The participant will take 2 capsules with 6-8 oz. of water per headache episode. With a max of 6 pills per day.

Secondary outcomes

  1. Understanding If HLNatural impacts the Intensity of Tension Headaches. Headaches.another intervention

    Time frame: Stubjects will be evaluated for up to 60 days or 3 episodes of a headache

    A diary will be kept of the intensity and need for other intervention during each episode.

  2. Outcome of all Adverse Events while consuming HLNatural Suppliement

    Time frame: All adverse events will be captured throughout the 60 days or after 3 episodes of headaches or until the subject exits the trial.

    Throughout the study the subject will capture any adverse events that have occurred. All events will recorded in the subject's diary.

  3. Outcome of Subjects Natural Behavior During the Clinical Trial

    Time frame: 10-point Mankoski Scale and Headache Diary will be at the start of the headache, 15 minutes after start of the event, 30 minutes after start of event and 60 minutes after the start of the event. The activity will be repeated for up to 3 events.

    Before the test product is taken the subject will complete a screening, demographic and baseline survey. At the end of the survey the researchers will use what is in the literature to help establish normal behavior. Upon completion of the study the participant will complete an exit study. The surveys and questionnaires will be used to establish normal behavior of the subject.

Sponsors and collaborators

Lead sponsor

Hawthorne Effect Inc.

Other

Collaborators

  • HLNatural, Inc.

Registry information

Official study title

Evaluation of the Impact of the HL Natural, Inc. Tension Relief Product on the Reduction of Symptoms in Adults Who Suffer From Mild to Moderate Tension Headaches

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Sep 17, 2019
Registry last updated
Nov 15, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.